These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33512163)

  • 1. Analogues of the Herbicide,
    Kandale A; Patel K; Hussein WM; Wun SJ; Zheng S; Tan L; West NP; Schenk G; Guddat LW; McGeary RP
    J Med Chem; 2021 Feb; 64(3):1670-1684. PubMed ID: 33512163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Pyrimidinedione Derivative with Potent Inhibitory Activity against Mycobacterium tuberculosis Ketol-Acid Reductoisomerase.
    Lin X; Kurz JL; Patel KM; Wun SJ; Hussein WM; Lonhienne T; West NP; McGeary RP; Schenk G; Guddat LW
    Chemistry; 2021 Feb; 27(9):3130-3141. PubMed ID: 33215746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.
    Krishna VS; Zheng S; Rekha EM; Nallangi R; Sai Prasad DV; George SE; Guddat LW; Sriram D
    Eur J Med Chem; 2020 May; 193():112178. PubMed ID: 32171154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads.
    Krishna VS; Zheng S; Rekha EM; Guddat LW; Sriram D
    J Comput Aided Mol Des; 2019 Mar; 33(3):357-366. PubMed ID: 30666485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of Mycobacterium tuberculosis ketol-acid reductoisomerase at 1.0 Å resolution - a potential target for anti-tuberculosis drug discovery.
    Lv Y; Kandale A; Wun SJ; McGeary RP; Williams SJ; Kobe B; Sieber V; Schembri MA; Schenk G; Guddat LW
    FEBS J; 2016 Apr; 283(7):1184-96. PubMed ID: 26876563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition studies of ketol-acid reductoisomerases from pathogenic microorganisms.
    Wun SJ; Johnson LA; You L; McGeary RP; Brueck T; Schenk G; Guddat LW
    Arch Biochem Biophys; 2020 Oct; 692():108516. PubMed ID: 32745463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, Synthesis and Evaluation of a Ketol-Acid Reductoisomerase Inhibitor.
    Bayaraa T; Kurz JL; Patel KM; Hussein WM; Bilyj JK; West NP; Schenk G; McGeary RP; Guddat LW
    Chemistry; 2020 Jul; 26(41):8958-8968. PubMed ID: 32198779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High throughput receptor-based virtual screening under ZINC database, synthesis, and biological evaluation of ketol-acid reductoisomerase inhibitors.
    Liu XH; Chen PQ; Wang BL; Dong WL; Li YH; Xie XQ; Li ZM
    Chem Biol Drug Des; 2010 Feb; 75(2):228-32. PubMed ID: 20028400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal Structures of Staphylococcus aureus Ketol-Acid Reductoisomerase in Complex with Two Transition State Analogues that Have Biocidal Activity.
    Patel KM; Teran D; Zheng S; Kandale A; Garcia M; Lv Y; Schembri MA; McGeary RP; Schenk G; Guddat LW
    Chemistry; 2017 Dec; 23(72):18289-18295. PubMed ID: 28975665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of branched-chain amino acid biosynthesis as potential antituberculosis agents.
    Grandoni JA; Marta PT; Schloss JV
    J Antimicrob Chemother; 1998 Oct; 42(4):475-82. PubMed ID: 9818746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological activities and SAR studies of new 3-substitutedphenyl-4-substitutedbenzylideneamino-1,2,4-triazole Mannich bases and bis-Mannich bases as ketol-acid reductoisomerase inhibitors.
    Wang BL; Zhang LY; Liu XH; Ma Y; Zhang Y; Li ZM; Zhang X
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5457-5462. PubMed ID: 29132751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activities of novel 5-substituted-1,3,4-oxadiazole Mannich bases and bis-Mannich bases as ketol-acid reductoisomerase inhibitors.
    Zhang Y; Liu XH; Zhan YZ; Zhang LY; Li ZM; Li YH; Zhang X; Wang BL
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4661-4665. PubMed ID: 27575481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel peptidomimetic peptide deformylase (PDF) inhibitors of Mycobacterium tuberculosis.
    Gokhale KM; Telvekar VN
    Chem Biol Drug Des; 2021 Jan; 97(1):148-156. PubMed ID: 32745362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
    Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrrolidine nucleoside bisphosphonates as antituberculosis agents targeting hypoxanthine-guanine phosphoribosyltransferase.
    Eng WS; Rejman D; Pohl R; West NP; Woods K; Naesens LMJ; Keough DT; Guddat LW
    Eur J Med Chem; 2018 Nov; 159():10-22. PubMed ID: 30265958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis.
    Prabu A; Hassan S; Prabuseenivasan ; Shainaba AS; Hanna LE; Kumar V
    J Mol Graph Model; 2015 Sep; 61():133-40. PubMed ID: 26245695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.